Deerland, Thione Jointly Debut First Antioxidant, Enzyme Development

Deerland Enzymes (Kennesaw, GA) and Thione International (Atlanta) have jointly released the first ingredient developed as a result of their formulation partnership announced last year. The ingredient, ThioZyme, combines antioxidants with “their vital partners,” antioxidant enzymes.

Large-dose single antioxidants can run the risk of becoming pro-oxidants, or free radicals, themselves after performing their antioxidant function, the companies say. However, the combination of antioxidants and enzymes in ThioZyme work synergistically to keep the body’s defense system functioning properly, both by providing direct antioxidant action and by regenerating antioxidants-including glutathione, one of the key components of the body’s antioxidant system. As a result, the combination enables a steady, balanced defense system against free radicals.

In fact, according to the companies, ThioZyme offers twice the antioxidant capacity of glutathione, according to Oxygen Radical Absorbance Capacity measurements. It is available as a standalone branded formula or can be further customized.

 “ThioZyme’s diverse antioxidant technology is based on tireless product testing and validation by the Deerland team, along with Dr. Hersh’s [Thione’s president and CEO] many years of research and his patented Thione Complex,” said Scott Ravech, CEO of Deerland Enzymes.